Page last updated: 2024-10-30

vitamin k 3 and Lung Diseases, Interstitial

vitamin k 3 has been researched along with Lung Diseases, Interstitial in 1 studies

Vitamin K 3: A synthetic naphthoquinone without the isoprenoid side chain and biological activity, but can be converted to active vitamin K2, menaquinone, after alkylation in vivo.

Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Schamberger, AC1
Schiller, HB1
Fernandez, IE1
Sterclova, M1
Heinzelmann, K1
Hennen, E1
Hatz, R1
Behr, J1
Vašáková, M1
Mann, M1
Eickelberg, O1
Staab-Weijnitz, CA1

Other Studies

1 other study available for vitamin k 3 and Lung Diseases, Interstitial

ArticleYear
Glutathione peroxidase 3 localizes to the epithelial lining fluid and the extracellular matrix in interstitial lung disease.
    Scientific reports, 2016, 07-20, Volume: 6

    Topics: Aged; Animals; Antioxidants; Bleomycin; Bronchi; Bronchoalveolar Lavage Fluid; Demography; Disease M

2016